Stoke Therapeutics' chief executive, Edward Kaye, is stepping down after more than seven years at the helm of the biotechnology company. Stoke on Tuesday said Ian Smith, a board member since September ...
Summit Therapeutics (SMMT) “announced that Robert LaCaze has joined Summit Therapeutics as Chief Commercial Officer, reporting to Manmeet S.
Kathy Nugent, Ph.D., executive director of the University of Alabama at Birmingham ’s Harbert Institute for Innovation and ...
Sage Therapeutics (NASDAQ:SAGE) traded lower for the third straight session on Tuesday after Bank of America moved the ...